<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087969</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00052299</org_study_id>
    <nct_id>NCT02087969</nct_id>
  </id_info>
  <brief_title>Triceps Surae Trigger Point Size and Muscle Extensibility</brief_title>
  <official_title>Effectiveness of Dry Needling to Decrease Trigger Point Size and Increase Soft Tissue Extensibility in the Triceps Surae Muscle as Measured Via Musculoskeletal Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of dry needling in improving&#xD;
      ankle range of motion and functional outcomes. There have been an increasing number of&#xD;
      studies on dry needling as an intervention for pain but none thus far that have studied&#xD;
      functional outcome measures of the ankle. The study will include healthy male subjects&#xD;
      between the ages of 18-30 years old randomized in to 3 intervention groups of: dry needling&#xD;
      of the triceps surae, triceps surae stretching only, dry needling and stretching. The&#xD;
      subjects who receive dry needling as an intervention will have the trigger point identified&#xD;
      and dry needling performed while under musculoskeletal ultrasound visualization. The subjects&#xD;
      will undergo pre and post intervention testing including Lower Quarter Y-Balance test,&#xD;
      passive ankle dorsiflexion, closed chain half kneeling dorsiflexion, standing dorsiflexion,&#xD;
      deep squat, multisegmental flexion as well as Marx Activity Level Scale. There will be 3 days&#xD;
      between the initial testing/intervention and follow up. These outcomes will be the primary&#xD;
      variables of interest. Ultrasound, Y balance testing, self stretching, and range of motion&#xD;
      measurements are safe and pose no risk to the subject. Dry Needling has been found to be very&#xD;
      safe and effective in the hands of physical therapists with a calculated risk of adverse&#xD;
      events to be less than 0.04%.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Ankle Dorsiflexion Range Of Motion</measure>
    <time_frame>Baseline and 10 Minutes</time_frame>
    <description>Ankle range of motion measures will be record before and immediately after the intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Ankle Dorsiflexion Range of Motion</measure>
    <time_frame>Baseline and 3 Days</time_frame>
    <description>Ankle dorsiflexion will again be measured at three days after the intervention to determine short term effectiveness of results.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Y-Balance Test for the Lower Quarter</measure>
    <time_frame>Baseline and 20 Minutes</time_frame>
    <description>Test of balance and functional performance of lower extremities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Y Balance Test for the Lower Quarter</measure>
    <time_frame>Baseline and 3 Days</time_frame>
    <description>Y Balance Test for the Lower Quarter will be assessed again at 3 days after the intervention to assess short term effectiveness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Limited Dorsiflexion</condition>
  <condition>Limited Ankle Range of Motion</condition>
  <arm_group>
    <arm_group_label>Dry Needling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dry Needling to Triceps Surae</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be given a home exercise program of stretches which are commonly prescribed to improve ankle dorsiflexion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dry Needling</intervention_name>
    <arm_group_label>Dry Needling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stretching</intervention_name>
    <arm_group_label>Stretching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  18-30 Years Old&#xD;
&#xD;
          -  No history of ankle surgery&#xD;
&#xD;
          -  No current ankle injuries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hypothyroidism&#xD;
&#xD;
          -  fibromyalgia&#xD;
&#xD;
          -  connective tissue disorders&#xD;
&#xD;
          -  chronic pain&#xD;
&#xD;
          -  bleeding disorders including use of anti-coagulants&#xD;
&#xD;
          -  vitamin D and B12 deficiencies&#xD;
&#xD;
          -  active sites of cancer&#xD;
&#xD;
          -  local or systemic infections&#xD;
&#xD;
          -  local skin lesions, local lymphedema&#xD;
&#xD;
          -  peripheral vascular disease including varicose veins&#xD;
&#xD;
          -  compromised immune system&#xD;
&#xD;
          -  needle phobia&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chad Cook, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke Sports Medicine</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>March 7, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

